SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

“Younger people are getting cancer more and more…we have to make kinder medicines.”

Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners

Once valued at $600 million, what went wrong at collapsing Believer Meats

Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race

Buzz

Most popular

Daily

Weekly

1

Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.

2

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

3

After over $390 million in funding, Believer Meats abruptly shuts down

4

Jensen Huang’s quiet role emerges as Argamani describes Nvidia’s two-year vigil for Avinatan Or

5

ServiceNow in advanced talks to acquire Armis at around $7 billion valuation

Forecasts

5 stories about Forecasts

CTech Forecast Conference Moran Alon

Pictet Wealth Management: “We're really, really focused on AI in 2024”

31.12.23|Ariela Karmel

CEO of Pictet Wealth Management’s Israel branch Moran Alon spoke to CTech at Calcalist’s 2024 Forecasts event about her outlook for the Israeli economy in 2024.

ועידת התחזיות 2022 מימין ניר צוק מייסד Palo Alto Networks ו אריק שטילמן מנכ"ל ושותף מייסד Rapyd

Nir Zuk faces criticism after saying high-earning techies should be heavily taxed

The founder of Palo Alto suggested increasing taxes for high-earning tech employees in order to bridge the gaps in Israeli society, but CEO of Rapyd Arik Shtilman called him out, claiming taxes are one of the reasons for the sector’s workforce shortage

‍ועידת התחזיות 2022 יואל אסתרון מו"ל כלכליסט

Wanted: A booster of humbleness for 2022

30.12.21|Yoel Esteron

“Let's be more humble, not only in our pretension to make forecasts, but also in life itself,” says Calcalist Publisher Yoel Esteron

תל אביב רמת גן מבט על מלמעלה

IMF Cuts Israel's Growth Forecast for 2019, Again

16.10.19|Adrian Filut

The International Monetary Fund lowered its growth forecast for Israel to 3.1%, after lowering it from 3.5% to 3.3% in April. It also cut its global growth forecast for this year, lowering it to 3% from the 3.2% it forecasted in July—the lowest forecast in a decade

מנכ"ל טבע החדש קור שולץ 2

Generic Dependence Threatens Teva’s Ability to Haul Debt Load

05.11.17|Dror Reich and Lilach Baumer

Teva’s stock price dropped 18.7% last week after the company lowered its annual forecasts. On Friday, S&P changed the company’s outlook to negative